NeoChord, Inc. (Eden Prairie, MN) is developing technology invented by cardiac surgeons at the Mayo Clinic who were looking for less invasive ways to repair the mitral valve for the treatment of degenerative mitral regurgitation. The NeoChord DS 1000 device allows sternal sparing, beating heart, apical access to the mitral valve and functions as a delivery system for the placement of artificial chordae tendineae (chords). Ruptured or elongated chords are the primary reason for surgery on the mitral valve today.
Copyright © 2020 Hopen Life Science Ventures - All Rights Reserved